The US Food and Drug Administration filed a supplemental brief on Tuesday requesting that the Supreme Court lift a preliminary injunction “barring the Food and Drug Administration (FDA) from enforcing longstanding safety requirements with respect to medication abortions effected through the use of Mifeprex (or its generic equivalent).
This pill is approved for use to manage miscarriages or end early pregnancy.
Both a district court and court of appeals have already denied the motions to lift the injunction even while the issue is on appeal.
